Dyne therapeutics market cap

WebGet the latest Dyne Therapeutics Inc (DYN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … WebApr 7, 2024 · See the latest Dyne Therapeutics Inc Ordinary Shares stock price (NASDAQ:DYN), related news, valuation, dividends and more to help you make your …

Investors & Media Dyne Therapeutics

WebMarket Cap ‎781.90M. Shares Outstanding ‎52.13M. EPS (TTM) ‎-3.2357. P/E (TTM) ‎-Fwd Dividend (% Yield) ‎-Ex-Dividend Date ‎- ... Dyne Therapeutics Inc. is a muscle disease company ... WebDyne Therapeutics, Inc. Analyst Report: Xcel Energy Inc. Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Discover historical prices for DYN stock on Yahoo Finance. View daily, weekly or … Get the detailed quarterly/annual income statement for Dyne Therapeutics, Inc. … View the basic DYN option chain and compare options of Dyne Therapeutics, … Find out the direct holders, institutional holders and mutual fund holders for … Dyne Therapeutics, Inc. 1560 Trapelo Road Waltham, MA 02451 United States 781 … See Dyne Therapeutics, Inc. (DYN) stock analyst estimates, including earnings … Find out all the key statistics for Dyne Therapeutics, Inc. (DYN), including … Dyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, … See Dyne Therapeutics, Inc. (DYN) Environment, Social and Governance … Find the latest Dyne Therapeutics, Inc. (DYN) stock quote, history, news and … simple strategic planning steps https://cannabimedi.com

Dyne Therapeutics, Inc. (NASDAQ:DYN) Given Average …

WebDyne Therapeutics (DYN) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Market Cap. $495.76M. Enterprise Value $263.49M. Total Cash (Recent Filing) $256.01M. Total Debt (Recent Filing) $30.48M. Price to Earnings (P/E)-2.7. Beta 0.93. Next … WebApr 10, 2024 · 5 brokerages have issued twelve-month target prices for Dyne Therapeutics' shares. Their DYN share price forecasts range from $18.00 to $34.00. On average, they … WebMar 23, 2024 · DYN Complete Dyne Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... Market Cap $646.76M; Shares Outstanding … raydiant lotion

Dyne Therapeutics, Inc. (DYN) Market Cap & Net Worth

Category:Dyne Therapeutics Company Profile: Stock Performance

Tags:Dyne therapeutics market cap

Dyne therapeutics market cap

Dyne Therapeutics Inc Ordinary Shares DYN Stock Quote

WebDyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle ... WebDyne Therapeutics (DYN) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ...

Dyne therapeutics market cap

Did you know?

WebJan 19, 2024 · Dyne was formed in 2024 and went public in 2024, raising net proceeds of $246.4 million at $19 a share. The stock trades near $13.50 a share, translating to a market cap of approximately $700 million. WebMar 24, 2024 · Dyne Therapeutics Inc Registered Shs's market capitalization is $642.40 M by 56.34 M shares outstanding. Dyne Therapeutics Stock Snapshot 11.04

WebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. ... Market Cap Shares Average Volume EPS; $9.38: $9.11: $4.30 - $15.63 ... WebDyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that …

WebApr 10, 2024 · Dyne Therapeutics Inc. company and executive profile by Barron's. View the latest DYN company infomation and executive bios. WebApr 11, 2024 · Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Rating) have earned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. ... The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. The business has a 50 day …

WebDYN stock forecast Our latest prediction for Dyne Therapeutics Inc's stock price was made on the Dec. 15, 2024 when the stock price was at 13.59$.. In the short term (2weeks), DYN's stock price should underperform the market by -4.52%.During that period the price should oscillate between -12.37% and +6.64%.. In the medium term (3months), DYN's stock …

WebJan 18, 2024 · Dyne Therapeutics had its IPO a year ago. The clinical-stage biotech has $407.5 million in cash but no revenue. The company specializes in treating serious … raydiant north fort myersWebReal time Dyne Therapeutics (DYN) stock price quote, stock graph, news & analysis. simple strategic plan template freeWebApr 12, 2024 · Market Cap Chart Since the IPO on September 17, 2024, Dyne Therapeutics, Inc.'s market cap has decreased from $790.90M to $480.56M, a … raydiant of brandonWebDyne Therapeutics Inc market cap is $489.02M. What is the 52-week high for Dyne Therapeutics Inc? 52 week high is the highest price of a stock in the past 52 weeks, or … raydiant nursing homes floridaWebYou can buy and sell Dyne Therapeutics (DYN) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. ... Market cap. 628.17M. Market cap 628.17M. Price-Earnings ratio-3.44. raydiant platformWebApr 11, 2024 · Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Rating) have earned an average rating of "Moderate Buy" from the seven ratings firms that are … raydiant nursing homesWebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. raydiant office